Anixa Biosciences Inc
ANIXNasdaqCIK 715446HealthcareFiscal year ends Oct 31
Reports and events: 234 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0916:15 ET | 10-Q | Quarterly reportPeriod 2026-07-31 | 0001493152-26-041963 |
| 2026-06-1016:15 ET | 10-Q | Quarterly reportPeriod 2026-04-30 | 0001493152-26-028105 |
| 2026-03-1117:03 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009699 |
| 2026-03-0916:16 ET | 10-Q | Quarterly reportPeriod 2026-01-31 | 0001493152-26-009370 |
| 2026-02-0908:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005702 |
| 2026-01-2816:16 ET | DEF 14A | Proxy statementPeriod 2026-01-28 | 0001493152-26-004035 |
| 2026-01-1216:01 ET | 10-K | Annual reportPeriod 2025-10-31 | 0001493152-26-001845 |
| 2026-01-0619:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-000691 |
| 2025-12-1218:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-027321 |
| 2025-09-1016:30 ET | 10-Q | Quarterly reportPeriod 2025-07-31 | 0001493152-25-013000 |
| 2025-06-0617:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-014126 |
| 2025-05-2816:20 ET | 10-Q | Quarterly reportPeriod 2025-04-30 | 0001641172-25-012701 |
| 2025-03-2116:15 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011151 |
| 2025-03-1116:20 ET | 10-Q | Quarterly reportPeriod 2025-01-31 | 0001493152-25-009854 |
| 2025-02-0616:15 ET | DEF 14A | Proxy statementPeriod 2024-10-31 | 0001493152-25-005199 |
| 2025-01-1017:18 ET | 10-K | Annual reportPeriod 2024-10-31 | 0001493152-25-001787 |
| 2025-01-0318:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-000323 |
| 2024-11-0813:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044224 |
| 2024-09-0617:00 ET | 10-Q | Quarterly reportPeriod 2024-07-31 | 0001493152-24-035335 |
| 2024-06-0417:00 ET | 10-Q | Quarterly reportPeriod 2024-04-30 | 0001493152-24-022573 |
| 2024-05-0808:35 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-018170 |
| 2024-05-0313:31 ET | SC 13D | Ownership report, active investor | 0001493152-24-017664 |
| 2024-03-2216:30 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-010995 |
| 2024-03-1217:00 ET | 10-Q | Quarterly reportPeriod 2024-01-31 | 0001493152-24-009683 |
| 2024-02-0816:15 ET | DEF 14A | Proxy statementPeriod 2024-02-08 | 0001493152-24-005470 |
| 2024-01-1617:29 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-002508 |
| 2024-01-1616:30 ET | 10-K | Annual reportPeriod 2023-10-31 | 0001493152-24-002453 |
| 2023-12-0706:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-043932 |
| 2023-09-0616:15 ET | 10-Q | Quarterly reportPeriod 2023-07-31 | 0001493152-23-031826 |
| 2023-06-1417:09 ET | 10-Q | Quarterly reportPeriod 2023-04-30 | 0001493152-23-021271 |
| 2023-04-1713:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-012483 |
| 2023-03-1721:29 ET | 10-Q | Quarterly reportPeriod 2023-01-31 | 0001493152-23-007994 |
| 2023-03-1008:00 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-007172 |
| 2023-01-2716:05 ET | DEF 14A | Proxy statementPeriod 2023-01-27 | 0001493152-23-002760 |
| 2023-01-0416:59 ET | 10-K | Annual reportPeriod 2022-10-31 | 0001493152-23-000346 |
| 2022-12-0808:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-034828 |
| 2022-09-2908:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-027121 |
| 2022-09-0916:15 ET | 10-Q | Quarterly reportPeriod 2022-07-31 | 0001493152-22-025490 |
| 2022-08-1710:44 ET | 8-K | 8.01 Other events | 0001493152-22-023285 |
| 2022-06-1016:22 ET | 10-Q | Quarterly reportPeriod 2022-04-30 | 0001493152-22-016452 |
| 2022-04-1509:52 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-010016 |
| 2022-03-1116:25 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-006637 |
| 2022-03-1116:05 ET | 10-Q | Quarterly reportPeriod 2022-01-31 | 0001493152-22-006618 |
| 2022-01-2816:00 ET | DEF 14A | Proxy statementPeriod 2022-01-28 | 0001493152-22-002541 |
| 2022-01-0416:06 ET | 10-K | Annual reportPeriod 2021-10-31 | 0001493152-22-000302 |
| 2021-12-0916:15 ET | 8-K | 5.08 Item not in the standard list | 0001493152-21-030965 |
| 2021-10-2816:54 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-21-026636 |
| 2021-10-0407:00 ET | 8-K | 8.01 Other events | 0001493152-21-024422 |
| 2021-09-0316:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-21-022017 |
| 2021-09-0116:46 ET | 10-Q | Quarterly reportPeriod 2021-07-31 | 0001493152-21-021799 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.